Meizhong Shuanghe

Beijing Meizhong Shuanghe Medical Devices Joint-stock Co., Ltd., established in 1999, has its factory located in the Miyun Economic Development Zone. The company's research team includes a number of senior talents in related fields such as biomaterials and mechanical engineering. It is the earliest high-tech enterprise in China focusing on the research, development, production, sales, and service of medical devices in the cardiac intervention field, with products and technologies centered on the cardiovascular product sector. Throughout its continuous development, the company has received attention and recognition from all sectors of society. In September 2009, it was recognized as a "National High-tech Enterprise" and successfully passed the re-examination in 2012. In April 2013, it was recognized as a "Zhongguancun High-tech Enterprise." In September 2011, it was awarded the title of "Potential Enterprise for the Beijing Biomedical Industry Leapfrog Development Project (G20 Project)" by the Beijing Municipal Science and Technology Commission, and was recognized as a "G20 Phase II Project Enterprise" in 2013. In May 2012, jointly with Beijing Hospital of the Ministry of Health and the Zhongguancun Yixin Medical Engineering Research Institute, it established the "Beijing Key Laboratory of Cardiovascular Drug and Device Technology and Evidence-based Medicine," which successfully passed the approval and recognition of the Beijing Municipal Science and Technology Commission. In 2022, it was recognized as a national-level specialized, refined, distinctive, and innovative "Little Giant" enterprise.